SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CUNEO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.134
AS - Asia 20.160
EU - Europa 10.683
SA - Sud America 3.326
AF - Africa 420
OC - Oceania 50
Continente sconosciuto - Info sul continente non disponibili 16
AN - Antartide 1
Totale 68.790
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.390
SG - Singapore 7.563
CN - Cina 4.896
BR - Brasile 2.623
VN - Vietnam 2.363
DE - Germania 2.091
UA - Ucraina 1.767
HK - Hong Kong 1.765
IT - Italia 1.655
TR - Turchia 1.289
GB - Regno Unito 1.020
FI - Finlandia 984
FR - Francia 778
RU - Federazione Russa 607
JP - Giappone 554
PL - Polonia 519
SE - Svezia 468
IN - India 386
MX - Messico 338
CA - Canada 307
ID - Indonesia 302
AR - Argentina 253
BD - Bangladesh 249
ZA - Sudafrica 175
NL - Olanda 156
IQ - Iraq 141
EC - Ecuador 115
ES - Italia 102
PK - Pakistan 102
CZ - Repubblica Ceca 95
BE - Belgio 94
CO - Colombia 79
UZ - Uzbekistan 78
AT - Austria 75
VE - Venezuela 74
CL - Cile 73
LT - Lituania 61
MA - Marocco 59
SA - Arabia Saudita 54
AE - Emirati Arabi Uniti 52
MY - Malesia 51
PH - Filippine 48
AU - Australia 44
TN - Tunisia 38
PY - Paraguay 35
KE - Kenya 32
JO - Giordania 30
PE - Perù 30
IL - Israele 29
EG - Egitto 27
IE - Irlanda 26
RO - Romania 25
BO - Bolivia 22
NP - Nepal 22
AZ - Azerbaigian 21
CH - Svizzera 21
DZ - Algeria 21
OM - Oman 21
DO - Repubblica Dominicana 19
TH - Thailandia 19
ET - Etiopia 18
UY - Uruguay 18
AL - Albania 16
RS - Serbia 16
KR - Corea 15
KZ - Kazakistan 15
JM - Giamaica 14
LV - Lettonia 14
IR - Iran 13
HU - Ungheria 12
PS - Palestinian Territory 12
TT - Trinidad e Tobago 12
EU - Europa 10
HR - Croazia 9
LB - Libano 9
PA - Panama 9
YE - Yemen 9
BG - Bulgaria 8
CR - Costa Rica 8
DK - Danimarca 8
SI - Slovenia 8
TW - Taiwan 8
BY - Bielorussia 7
CI - Costa d'Avorio 7
KG - Kirghizistan 7
PT - Portogallo 7
BB - Barbados 6
BH - Bahrain 6
HN - Honduras 6
MD - Moldavia 6
NG - Nigeria 6
NI - Nicaragua 6
PR - Porto Rico 6
GE - Georgia 5
LY - Libia 5
QA - Qatar 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
GR - Grecia 4
ME - Montenegro 4
Totale 68.695
Salva come PNG Salva come JPEG
Città #
Singapore 4.812
Ashburn 3.872
Fairfield 3.017
Woodbridge 2.968
Houston 2.048
San Jose 1.891
Jacksonville 1.863
Hong Kong 1.738
Chandler 1.678
Beijing 1.544
Santa Clara 1.414
Ann Arbor 1.362
Seattle 1.178
Wilmington 1.132
Cambridge 977
Ho Chi Minh City 720
Izmir 649
Nanjing 593
Los Angeles 548
Tokyo 536
New York 526
Dallas 521
Hanoi 519
Warsaw 487
Munich 482
Princeton 480
Lauterbourg 436
Helsinki 408
Council Bluffs 356
San Diego 314
Boardman 309
Ferrara 280
São Paulo 267
Milan 264
Shanghai 224
Mexico City 219
Jakarta 206
Shenyang 190
Nanchang 172
Turku 171
Orem 145
London 140
Dong Ket 132
Hebei 128
Buffalo 126
Tianjin 120
Chicago 118
Bremen 115
Hefei 114
Addison 113
Haiphong 111
Da Nang 110
Montreal 106
Changsha 101
Chennai 98
Johannesburg 91
Moscow 91
Rio de Janeiro 91
Toronto 91
Brussels 90
Falls Church 88
Jiaxing 88
Brooklyn 86
Dearborn 83
Frankfurt am Main 82
Denver 77
Phoenix 75
Jinan 74
Zhengzhou 72
Stockholm 71
Mountain View 69
Rome 66
San Francisco 66
Tashkent 65
Redwood City 63
Atlanta 62
Biên Hòa 62
Brasília 59
Falkenstein 59
Baghdad 58
Manchester 57
Poplar 57
Guangzhou 56
Norwalk 55
Nuremberg 54
Belo Horizonte 52
Bologna 51
Brno 51
Lappeenranta 51
The Dalles 51
Amsterdam 50
Curitiba 50
Hải Dương 48
Kunming 46
San Mateo 46
Boston 45
Mumbai 45
Quito 45
Dhaka 40
Ningbo 40
Totale 46.017
Salva come PNG Salva come JPEG
Nome #
A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. 408
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 313
Aberrant expression of HLA-DR antigen by bone marrow-derived mesenchymal stromal cells from patients affected by acute lymphoproliferative disorders 292
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 286
Acute Human Herpesvirus-6A infection of human mesothelial cells modulates HLA molecules 284
CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis 284
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 274
The anti-leukemic activity of sodium dichloroacetate in p53(mutated/null) cells is mediated by a p53-independent ILF3/p21 pathway 273
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 272
Sodium dichloroacetate exhibits anti-leukemic activity in B-chronic lymphocytic leukemia (B-CLL) and synergizes with the p53 activator Nutlin-3 272
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 271
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 270
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 267
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 264
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 264
A decreased positivity for CD90 on human mesenchymal stromal cells (MSCs) is associated with a loss of immunosuppressive activity by MSCs 264
A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma 263
Individual quality assessment of autografting by probability estimation for clinical endpoints: a prospective validation study from the European group for blood and marrow transplantation 262
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 261
The active metabolite of warfarin (3′-hydroxywarfarin) and correlation with INR, warfarin and drug weekly dosage in patients under oral anticoagulant therapy: A pharmacogenetics study 260
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 259
Preferential expression of the transcription coactivator HTIF1alpha gene in acute myeloid leukemia and MDS-related AML 258
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 258
5' region and exon 7 mutations of the TP53 gene in two cases of B-cell prolymphocytic leukemia 256
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 256
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 252
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 252
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells from different sources. Evidence of discordant reactivity for various immunological markers 252
A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells 248
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 248
Acquired chromosome 11q deletion involving the ataxia teleangiectasia locus in B-cell non-Hodgkin's lymphoma: Correlation with clinicobiologic features 247
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 247
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 241
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia. 239
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 239
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 238
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 238
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 235
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 234
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 233
B-Cell chronic lymphocytic leukemia (B-CLL) with 14q32 translocations: haematological features and clinical outcome. 231
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 227
Fluorescence in situ hybridization for the detection and monitoring of the Ph-positive clone in chronic myelogenous leukemia: Comparison with metaphase banding analysis 227
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 227
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 227
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 226
Employment of Oligodeoxynucleotide plus Interleukin-2 Improves Cytogenetic Analysis in SplenicMarginal Zone Lymphoma 225
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 225
Novel small deletions of the p53 gene in late stage B-cell chronic lymphocytic leukaemia 223
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 223
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 223
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 222
Secondary chromosome changes in mantle cell lymphoma: Cytogenetic and fluorescence in situ hybridization studies 221
Exposure to myelotoxic agents and myelodysplasia: Case-control study and correlation with clinicobiological findings 221
Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia 220
A Prospective, Multi Center Phase II Study Evaluating Predictive Factors for Lenalidomide Treatment in Relapse or Refractory Chronic Lymphocytic Leukemia Patients (LE.P.RE.): Preliminary Results about the First 20 Enrolled Patients 219
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 218
Delirium in acute promyelocytic leukemia patients: Two case reports 218
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 217
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 216
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 216
Alterazioni cromosomiche in cellule staminali emopoietiche indotte da esposizioni ambientali o professionali. 215
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 215
REFINED KARYOTYPE-BASED PROGNOSTIC STRATIFICATION OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH A VERY LOW RISK GENETIC PROFILE 213
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 212
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 212
Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL) 211
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 210
Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation 209
A novel translocation t(1;7)(p36;q34) in three patients with acute myeloid leukaemia 208
Differentiation of follicular dendritic sarcoma cells into functional myeloiddendritic cell-like elements 206
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 206
Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation 205
Molecular cytogenetic characterization of marginal zone B-cell lymphoma: correlation with clinicopathologic findings in 14 cases 205
Therapy-related adult acute lymphoblastic leukemia with t(4;11)(q21;q23): MLL rearrangement, p53 mutation and multilineage involvement 205
[Use of 5-phosphodiesterase inhibitors in patients with LUTS secondary to BPH: our experience and review of the literature]. 204
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 204
Four novel non-random chromosome rearrangements in B-cell chronic lymphocytic leukaemia: 6p24-25 and 12p12-13 translocations, 4q21 anomalies and monosomy 21 204
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 203
MORFOLOGIA E FISIOPATOLOGIA DEL SANGUE E DEGLI ORGANI EMOPOIETICI 203
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: Cytologic and cytogenetic evidence in thirty-four patients 202
Detection of inherited chromosomally integrated HHV-6 (ciHHV-6) in a marker chromosome 200
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 200
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 198
Abnormalities of chromosomes 1p34-36, 4p16, 4q35, 9q11-32 and +7 represent novel recurrent cytogenetic rearrangements in chronic lymphocytic leukemia 198
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 197
Dendritic cells in acute promyelocytic leukaemia 196
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 196
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 196
In chronic lymphocytic leukaemia, SLAMF1 deregulation is associated with genomic complexity and independently predicts a worse outcome 196
Cytogenetic and molecular cytogenetic characterization of 6 new cases of idiopathic hypereosinophilic syndrome 193
Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features 193
Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation 193
Myelofibrosis with Myeloid Metaplasia (MMM)/Idiopathic myelofibrosis/Agnogenic myeloid metaplasia 193
A Molecular Model to Predict Durable Remission after First Line Fludarabine-Cyclophosphamide-Rituximab Treatment in Chronic Lymphocytic Leukemia 191
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biological significance 190
Waldenstrom macroglobulinemia 190
Mobilization of endothelial progenitor cells in patients with hematological malignancies after treatment with granulocyte colony stimulating factor and chemotherapy for autologous transplantation 189
Hepatosplenic T-cell lymphoma (HSTCL). 189
Multilineage involvement in the 5q- syndrome: A fluorescent in situ hybridization study on bone marrow smears 189
Totale 23.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 311.672
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 37.981
Totale 349.653
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.243 0 0 0 0 0 0 0 0 0 0 779 464
2021/20224.235 230 531 203 195 226 230 230 260 138 359 427 1.206
2022/20234.073 500 178 138 464 698 594 181 363 560 21 250 126
2023/20242.042 186 284 97 50 128 283 89 111 65 55 79 615
2024/20259.403 315 200 787 324 1.145 746 242 510 1.537 1.225 1.265 1.107
2025/202626.382 2.382 1.385 2.438 3.786 3.813 1.830 2.994 1.538 2.802 3.242 172 0
Totale 69.568